...
首页> 外文期刊>Journal of endocrinological investigation. >Glucose control in type 1 diabetes and COVID-19
【24h】

Glucose control in type 1 diabetes and COVID-19

机译:Glucose control in type 1 diabetes and COVID-19

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We would like to share ideas on "Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring [1]." Longo et al. concluded that "Young home-isolated patients with type 1 diabetes and COVID-19 showed a worsening of... infection [1]." In general, COVID-19 can affect glucose metabolism and it might result in elevation of blood glucose and hemoglobin A1C [2]. If there is no good diabetic care during COVID-19 illness, the DM patient under home isolation might have poor glucose control. In the present report, there are many confounding factors that might affect the observation on diabetic control. The severity of COVID-19 cases might be associated with outcome and there should be subgroup analysis. Additionally, medication used by patient should be mentioned. In our setting, Asia, many COVID-19 patients use alternative therapy and it can result in high blood glucose level. Furthermore, the use of telemedical care should be discussed. Whether the telemedicine care includes specific session on diabetic care is an interesting question.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号